The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">FEC 100/FAC</td><td class="align_center">Breast</td></tr><tr><td class="align_center" colspan="2"><hr/></td></tr><tr><td class="align_left">ABVD</td><td class="align_center">Hodgkin’s lymphoma</td></tr><tr><td class="align_center" colspan="2"><hr/></td></tr><tr><td class="align_left">CHOP</td><td class="align_center">Non-Hodgkin’s lymphoma</td></tr><tr><td class="align_center" colspan="2"><hr/></td></tr><tr><td class="align_left">CDDP paclitaxel</td><td class="align_center">Head and neck</td></tr><tr><td class="align_center" colspan="2"><hr/></td></tr><tr><td class="align_left">CDDP/5FU</td><td class="align_center">Head and neck</td></tr><tr><td class="align_center" colspan="2"><hr/></td></tr><tr><td class="align_left">IAP</td><td class="align_center">Osteosarcoma</td></tr><tr><td class="align_center" colspan="2"><hr/></td></tr><tr><td class="align_left">ECF</td><td class="align_center">Stomach</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Chemotherapy Research and Practice

tab2

Table 2

Table 2: The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India 